LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · IEX Real-Time Price · USD
1.870
-0.090 (-4.59%)
Jun 21, 2024, 12:59 PM EDT - Market open

LAVA Therapeutics Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Year
20232022202120202019
Net Income
-41.97-31.91-42.36-15.93-9.69
Depreciation & Amortization
1.280.780.560.460.26
Share-Based Compensation
5.044.113.910.560.19
Other Operating Activities
-3.3231.069.245.60.62
Operating Cash Flow
-38.974.04-28.65-9.31-8.62
Capital Expenditures
-0.73-0.59-0.76-0.5-0.76
Change in Investments
-16.919.93-42.780-0.03
Investing Cash Flow
-17.649.35-43.55-0.5-0.79
Share Issuance / Repurchase
00.0289.02-4.850
Debt Issued / Paid
-0.570.270.341.791.18
Other Financing Activities
--61.822.03-
Financing Cash Flow
-0.570.28151.1618.971.18
Exchange Rate Effect
1.08-4.21-3.92-0.68-0.43
Net Cash Flow
-57.1813.6778.979.16-8.23
Free Cash Flow
-39.73.46-29.41-9.81-9.38
Free Cash Flow Margin
-586.53%17.82%-549.74%-261.78%-
Free Cash Flow Per Share
-1.490.13-1.49-24.58-20.95
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).